Cardiology Headline News

SAN DIEGO — During 2019 and 2020, patients with pulmonary arterial hypertension lost around 8% of available workdays, according to research presented at the American Thoracic Society International Conference.

A single burst of antitachycardia pacing before an implantable cardioverter defibrillator shock lowered risk for all-cause shock compared with a standard shock protocol, according to the results of the APPRAISE ATP trial.

A structurally normal heart was the most common finding among athletes who experienced sudden cardiac death, but the cause and circumstance of death varied significantly by the athletes’ race, researchers reported.

SAN DIEGO — Type 2 inflammation and asthma were significantly associated with higher risk for coronary artery disease, according to a presentation at the American Thoracic Society International Conference.

SAN DIEGO — Between 2017 and 2023, the highest rate of pulmonary embolism admissions was found in 2021 during the COVID-19 pandemic, according to research presented at the American Thoracic Society International Conference.

Due to a small increase in eczematous dermatitis, older adults taking antihypertensive drugs should be monitored and this possibility considered when assessing for eczema, according to a study.

Preeclampsia appeared to increase primiparous women’s risk for developing arrhythmia, according to results of a real-world study published in European Journal of Preventative Cardiology.

Both step counts and time-based physical activity reduced the risks of death and CVD among women aged 62 years and older, a study in JAMA Internal Medicine showed.

Topical hypericin showed efficacy in treating mycosis fungoides without significant skin absorption or significant cardiac changes, according to a study.

Roche announced its lipoprotein(a) assay received breakthrough device designation from the FDA to identify patients with history of atherosclerotic CVD who may benefit from Lp(a)-lowering therapy currently in development.